TURN THERAPEUTICS INC
TTRX·90021W105·US·Common Stock·Healthcare - Biotechnology-13D/G
TTRX (TURN THERAPEUTICS INC) is held by 12 institutional investors as of Q1 2026. Largest holders: MILLENNIUM MANAGEMENT LLC ($223,222), VANGUARD CAPITAL MANAGEMENT LLC ($158,240), BROWN BROTHERS HARRIMAN & CO ($75,802). Net institutional sentiment: Mixed.
12
Holders
Avg rating(5 Elite)
$802,406
Total Value
44% (15)
Fund Consensus
4 buying - 5 selling
Who's Trading
ActivistBBBradley Burnam52.8%Apr 6, 2026
InsiderCZChaudhary ZuraizBuy $9KDec 12, 2025
InsiderGFGOLDEN ARTHUR FBuy $34KNov 24, 2025
InsiderGFGOLDEN ARTHUR FBuy $59KNov 21, 2025
InsiderCZChaudhary ZuraizBuy $3KNov 21, 2025
InsiderCZChaudhary ZuraizBuy $4KNov 20, 2025
InsiderCZChaudhary ZuraizBuy $9KNov 17, 2025
InsiderCAChesed AbrahamBuy $66KOct 23, 2025
InsiderGFGOLDEN ARTHUR FBuy $100KOct 23, 2025
InsiderCZChaudhary ZuraizBuy $25KOct 23, 2025
13F: Insider & Congress:
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer